CD28 co-stimulatory domain enhances efficacy of CERT cell therapy compared to 4-1BB in an ovarian cancer mouse model
Favorite
Share
More Options
17

Open in WPS to view all 17 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
